Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.94 Analyst target: $3.70 Upside: 293.62%
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company is headquartered in Washington, District of Columbia.
See the full interactive analysis & chart →Informational only — not investment advice.